[en] The efficacy and the safety of parenteral sulbactam/ampicillin followed by oral sultamicillin* has been evaluated in 41 children aged between 0.5 and 15 years presenting with various infections.Overall clinical and bateriologial success was achieved in 92% of evaluable cases; 97% of 22 pathogens isolated in these patients were eradicated. Adverse reactions were pain at the intramuscular injections site (7%) which was minimized by concurrent injection of lidocaine. Gastro-intestinal disturbances with soft stools were common during oral sultamicillin therapy. Laboratory tests remained normal. Parental sulbactam/ampicillin followed by oral sultamicillin is useful therapy for the treatment of serious non-life-threatening paediatric infections.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.